STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

May 28, 2019
Open Access

HiChIRP reveals RNA-associated chromosome conformation

Nature Methods
Maxwell R MumbachHoward Y Chang
March 6, 2020

Direct binding to NLRP3 pyrin domain is a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis

Arthritis & Rheumatology
Gabsik YangJoo Y Lee
October 11, 2019
Open Access

STING signaling is a potential immunotherapeutic target in colorectal cancer

Journal of Cancer
Hong Jae ChonChan Kim
May 18, 2020

PCBP1 modulates the innate immune response by facilitating the binding of cGAS to DNA

Cellular & Molecular Immunology
Chen-Yang LiaoHong-Bing Shu
September 19, 2019
Open Access

PTPN1/2-mediated dephosphorylation of MITA/STING promotes its 20S proteasomal degradation and attenuates innate antiviral response

Proceedings of the National Academy of Sciences of the United States of America
Tian XiaHong-Bing Shu
July 20, 2019
Open Access

MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling

Cell Communication and Signaling : CCS
Engin BaturcamDanen Mootoosamy Cunoosamy
November 24, 2019
Open Access

Bioactive modulators targeting STING adaptor in cGAS-STING pathway

Drug Discovery Today
Xi FengJinlei Bian
August 1, 2020
Open Access

STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression

Nature Communications
Jesse J BalicAshley Mansell
July 17, 2020

STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets

Science Translational Medicine
Cameron S BaderRobert B Levy
September 13, 2019

SNX8 modulates the innate immune response to RNA viruses by regulating the aggregation of VISA

Cellular & Molecular Immunology
Wei GuoQing Yang
February 11, 2020
Open Access

Long Non-coding RNA LincRNA-EPS Inhibits Host Defense Against Listeria monocytogenes Infection

Frontiers in Cellular and Infection Microbiology
Federica AglianoAndrei E Medvedev
June 26, 2020

Long non-coding RNAs in antiviral immunity

Seminars in Cell & Developmental Biology
Tim Vierbuchen, Katherine A Fitzgerald
August 8, 2019

The zinc-finger protein ZFYVE1 modulates TLR3-mediated signaling by facilitating TLR3 ligand binding

Cellular & Molecular Immunology
Xuan ZhongHong-Bing Shu
June 2, 2020
Open Access

Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma

Frontiers in Oncology
Sandhya ChipurupalliNirmal Robinson
May 24, 2019
Open Access

A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1

Baoyu ZhaoPingwei Li
October 5, 2019
Open Access

Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice

Scientific Reports
Gary R MartinFrank R Jirik
August 21, 2019
Open Access

Assembling the Inflammasome, Piece by Piece

The Journal of Immunology : Official Journal of the American Association of Immunologists
Fiachra Humphries, Katherine A Fitzgerald
July 30, 2019
Open Access

STING pathway agonism as a cancer therapeutic

Immunological Reviews
Blake A FloodThomas F Gajewski

Sign up to follow this feed and discover related papers.

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.


Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

© 2020 Meta ULC. All rights reserved